Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
Although psoriatic arthritis (PsA) primarily leads to joint and skin damage, it is associated with higher prevalence of metabolic syndrome (MetS) and its components, namely hypertension, dyslipidemia, obesity, and type II diabetes. Additionally, chronic inflammation is known to aggravate these cardi...
Main Authors: | Fabiola Atzeni, Elisabetta Gerratana, Ignazio Francesco Masala, Sara Bongiovanni, Piercarlo Sarzi-Puttini, Javier Rodríguez-Carrio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.735150/full |
Similar Items
-
Cardiovascular risk in psoriatic arthritis
by: V V Badokin, et al.
Published: (2009-06-01) -
Peculiarities of dyslipidemia in patients with psoriatic arthritis: connection with atherosclerosis, cardiovascular risk factors and inflammation activity
by: Rebrov A.P., et al.
Published: (2010-09-01) -
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
by: Zarema R. Khismatullina, et al.
Published: (2021-04-01) -
COMORBIDITIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: Zhdan V. M., et al.
Published: (2020-12-01) -
IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)